Epilepsies Clinical Trials

2 recruiting

Epilepsies Trials at a Glance

9 actively recruiting trials for epilepsies are listed on ClinicalTrialsFinder across 6 cities in 7 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in Paris, Ehime, and Fukushima. Lead sponsors running epilepsies studies include Fondation Ophtalmologique Adolphe de Rothschild, Boston Children's Hospital, and Azienda Ospedaliero-Universitaria di Modena.

Browse epilepsies trials by phase

Treatments under study

About Epilepsies Clinical Trials

Looking for clinical trials for Epilepsies? There are currently 2 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Epilepsies trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Epilepsies clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting

Genetic and Electrophysiologic Study in Focal Drug-resistant Epilepsies

Drug-resistant Focal Epilepsies in Pediatric Population
Fondation Ophtalmologique Adolphe de Rothschild450 enrolled1 locationNCT02890641
Recruiting
Not Applicable

High-resolution Multi-parametric Magnetic Resonance Imaging for Focal Epilepsy

Epilepsies, Partial
Chinese University of Hong Kong66 enrolled1 locationNCT06550726
Recruiting

Registry and Natural History Study for Progressive Myoclonus Epilepsy Type 1 (EPM1)

Progressive Epilepsy and/or Ataxia With Myoclonus as a Major FeatureProgressive Myoclonus Epilepsy Type 1EPM1+5 more
Boston Children's Hospital200 enrolled1 locationNCT06593951
Recruiting
Not Applicable

Chinese-Specific Speech Imagery Coding Using High-Density ECoG

StrokeALSAphasia+5 more
Second Affiliated Hospital, School of Medicine, Zhejiang University50 enrolled1 locationNCT07460037
Recruiting

Impact of Epileptic Discharge on the Structural Connectivity of the Developing Brain

PediatricsDrug Resistant EpilepsyEpilepsies, Focal
Fondation Ophtalmologique Adolphe de Rothschild82 enrolled1 locationNCT03268824
Recruiting
Phase 2

Safety of Cenobamate in Japanese Subjects With Partial Onset Seizures

Epilepsies, Partial
Ono Pharmaceutical Co., Ltd.100 enrolled29 locationsNCT06590896
Recruiting
Phase 4

A Clinical Study on the Efficacy and Safety of Zonisamide as a First Add-On Treatment in Epileptic Seizures

Epilepsy, Tonic-ClonicEpilepsies, Partial
Affiliated Hospital of Nantong University30 enrolled1 locationNCT06967012
Recruiting
Not Applicable

Home Ultra-long Term EEG Monitoring for Rare Epilepsies and Developmental and Epileptic Encephalopathies

EpilepsiesEpilepsies, FocalEpileptic Encephalopathy
Azienda Ospedaliero-Universitaria di Modena30 enrolled4 locationsNCT06855901
Recruiting
Phase 2

Treating Postictal Symptoms Using Ibuprofen and Nifedipine

EpilepsyEpilepsies, Partial
University of Calgary90 enrolled2 locationsNCT03949478